According to VentureBeat, HoloMD just closed the first $1.6 million tranche of its $3 million seed round and will host a virtual investor presentation on November 11, 2025 at 12:00 p.m. ET. The funding will accelerate development of Dr. Holo, their AI-powered mental health platform that supports psychiatrists and patients between visits. The company has already completed Phase 1 of its rollout, moving from concept to live revenue in just 15 months. Early deployments have shown strong patient engagement and validated RTM billing across multiple commercial payers. Interested investors can RSVP to Dominic Fabrizio at [email protected] for the 45-minute presentation.
Sponsored content — provided for informational and promotional purposes.
The reimbursement angle is everything
Here’s what makes HoloMD interesting – they’re not just another mental health app. They’ve built their entire platform around Remote Therapeutic Monitoring (RTM) reimbursement codes. Basically, they’re turning what was previously unpaid work between patient visits into billable services. That’s huge for psychiatrists who’ve been drowning in uncompensated follow-up work.
And they’re not just claiming it works – they say they’ve already proven the reimbursement model with multiple commercial payers. In today’s healthcare landscape, that’s the difference between a nice idea and a sustainable business. The platform structures interactions to be CPT-compliant, which means providers can actually get paid for using it.
AI with training wheels
What strikes me about their approach is the “human-supervised” part. Every interaction with Dr. Holo gets reviewed by licensed clinicians. That’s smart – it addresses the biggest concern about AI in mental health: safety and accuracy. They’re essentially using AI to scale the routine stuff while keeping humans in the loop for quality control.
But here’s my question – how scalable is that model really? If they’re reviewing every single patient interaction, the costs could add up quickly. The balance between automation and human oversight will be their constant challenge as they grow.
Right place, right time?
They launched in July 2024 and claim to already have revenue and validated billing. That’s lightning fast for healthcare. The mental health tech space is crowded, but their focus on psychiatry specifically and their reimbursement strategy sets them apart from consumer-focused apps.
Now, with HoloMD planning to expand into additional practices and markets, the timing seems right. Mental health needs are through the roof, provider burnout is real, and everyone’s looking for solutions that actually work within our messy healthcare system. If they can prove their model at scale, this could be more than just another wellness app – it might actually change how psychiatric care gets delivered between those expensive office visits.
